Does insulin drive theca-cell androgen production and amplify LH to create a self-perpetuating loop in PCOS?

Polycystic Ovary Syndrome (PCOS) is characterized by a complex endocrine imbalance where insulin and luteinizing hormone (LH) interact to drive excess androgen production. Research confirms that hyperinsulinemia is not merely a metabolic byproduct of the condition but a primary driver of ovarian dysfunction.

Clinical and effectiveness evidence

Extensive clinical data, including hyperinsulinemic-euglycemic clamp studies and cell culture models, demonstrate that insulin directly stimulates ovarian theca cells to produce androgens.

• Direct Stimulation: In human theca cell cultures, insulin treatment results in a 2- to 4-fold increase in the secretion of androstenedione and testosterone.
• LH Synergism: Insulin acts as a "co-gonadotropin," significantly magnifying the effect of LH. Co-treatment with both hormones can increase androgen production by 5 to 10 times compared to either hormone alone.
• Clinical Correlation: In women with PCOS, a strong correlation exists between fasting insulin levels and circulating androgens (r > 0.6). Furthermore, insulin-sensitizing treatments (e.g., metformin) typically reduce androgen levels by 20–40%.

Mechanistic explanations

The "vicious cycle" of PCOS is driven by a phenomenon known as tissue-specific insulin resistance. While metabolic tissues like skeletal muscle become resistant to insulin, the ovarian theca cells remain highly sensitive to its steroidogenic effects.

• Enzymatic Activation: Insulin upregulates the expression and activity of CYP17A1 (17α-hydroxylase/17,20-lyase), the rate-limiting enzyme in androgen synthesis. It also increases StAR protein expression, which facilitates cholesterol transport into the mitochondria.
• Signaling Pathways: These effects are mediated through the PI3K/Akt and MAPK/ERK pathways. Even when systemic insulin resistance is present, these specific ovarian pathways remain overactive.
• The Loop: High insulin levels drive high androgens; these androgens, in turn, promote abdominal adiposity and alter muscle metabolism, which further worsens systemic insulin resistance and leads to higher compensatory insulin production.

Bottom line

The claim is strongly supported by scientific evidence. Insulin directly stimulates theca cell androgen production and synergistically amplifies the effects of LH, creating a self-perpetuating feedback loop that centralizes hyperinsulinemia as a key therapeutic target in PCOS management.